HAMDEN, CT June 27, 2009 – Dr. Eugene Redmond, MD, RxGen scientist and co-founder, and Director of St. Kitts Biomedical Research Foundation, will be speaking at at the Teratology Society annual meeting, being held in San Juan, Puerto Rico June 27 – July 1, 2009. Dr. Redmond will be presenting work related to further characterization ...
Continue Reading »
RxGen and Santaris Pharma Use LNA Technology to Suppress a MicroRNA in Liver of a Non-Human Primate and Safely Lower Serum Cholesterol
Hamden, CT and Hørsholm, Denmark --- Business Wire March 27, 2008 --- In a study published in the journal Nature today, Santaris Pharma and RxGen, Inc., a specialty pharma services company demonstrated that locked ...
Continue Reading »
HAMDEN, CT March 15, 2009 – RxGen and Santaris Pharma announce the recent conclusion of a highly successful three day scientific meeting in St. Kitts, West Indies. The meeting was designed to engage leading scientists and postdoctoral students working in all aspects of microRNA research in a symposium addressing microRNA biology and its involvement in ...
Continue Reading »
RxGen Appoints Steve Gullans to Chairman and Matthew Lawrence to President and CSO
Hamden, CT April 2, 2008 -- RxGen Inc. announces the promotion of Matthew Lawrence, Ph.D., M.D, to the position of President and Chief Scientific Officer. Dr. Lawrence will replace Steve Gullans, who had previously held the position of President and CEO and who ...
Continue Reading »
RxGen, Inc. and Dr. Keith Ward Begin Publishing African Green Monkey Validation Work
Hamden, CT February 1st, 2008 --- As part of its ongoing preclinical model validation initiative, RxGen announces that the company has begun to publish on the pharmacokinetic behavior of compounds in the African green monkey. The work, to be published in conjunction with ...
Continue Reading »